Morningstar Investor users sign in here.

China Regenerative Medicine International Ltd

08158

Company Profile

  • Business description

    China Regenerative Medicine International Ltd is a biotechnology company that researches and commercializes regenerative medicine products in China. The group has one reportable segment: healthcare products and services - production with sales of healthcare products and services. The vast majority of the company's revenue is derived from its healthcare products and services segment. Geographically, the People's Republic of China accounts for the majority of the revenue.

  • Contact

    132 Nathan Road
    Suite 2310–18, Miramar Tower
    Tsim Sha Tsui
    Kowloon
    HKG

    T: +852 39189000

    http://www.crmi.hk

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2024

    Employees

    46

Stocks News & Analysis

video

Impact of the supermarkets code of conduct

Morningstar Director of Equity Research Johannes Faul explains the impact of the political hot water that Coles and Woolworths face. 
stocks

Four cheap wide moat ASX stocks

We follow Buffett’s adage to find great companies trading at attractive prices. 
stocks

5 top US dividend shares from the best managers

These cheap dividend stocks are popular among highly rated concentrated fund managers.

Market Movers

Name
Last price
Change
% Change
Sayona Mining Ltd SYA 0.04 0.00 0.00%
The Star Entertainment Group Ltd SGR 0.42 0.00 0.00%
Zip Co Ltd ZIP 1.18 0.01 -0.84%
Renascor Resources Ltd RNU 0.11 0.02 26.51%
Imugene Ltd IMU 0.08 0.00 0.00%
Strickland Metals Ltd STK 0.14 0.02 12.50%
Droneshield Ltd DRO 1.12 0.18 18.52%
Telstra Group Ltd TLS 3.68 0.00 0.00%
Red 5 Ltd RED 0.43 0.01 1.18%
Evolution Mining Ltd EVN 4.16 0.29 7.49%